Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein

Eur Rev Med Pharmacol Sci. 2016 Jul;20(14):2947-9.
No abstract available

Publication types

  • Letter